Ionis Pharmaceuticals (IONS) PT Lowered to $31 at Stifel Following Earnings, Focus Remains on Key Readouts from Pipeline
Tweet Send to a Friend
Stifel analyst Paul Matteis lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $31.00 (from $38.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
